Softcare Limited (HKG:2698)
Hong Kong · Delayed Price · Currency is HKD 25.54
+0.60 (2.41%)
Oct 23, 2026, 4:08 PM HKT
Softcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 645.5 | 567.39 | 454.39 | 411.37 | 319.9 | |
Revenue Growth | - | 24.87% | 10.46% | 28.59% | - |
Cost of Revenue | 410.01 | 363.88 | 294.24 | 267.62 | 246.37 |
Gross Profit | 235.49 | 203.5 | 160.15 | 143.75 | 73.53 |
Selling, General & Admin | 65.79 | 59.1 | 44.14 | 49.15 | 37.84 |
Research & Development | 0.97 | 1.18 | 0.53 | 0.34 | 0.16 |
Operating Expenses | 66.77 | 60.27 | 44.67 | 49.49 | 37.99 |
Operating Income | 168.72 | 143.23 | 115.48 | 94.25 | 35.54 |
Interest Expense | -1.03 | -1.42 | -0.46 | -1.39 | -6.98 |
Interest & Investment Income | 8.31 | 1.93 | 0.39 | 0.39 | 0.05 |
Currency Exchange Gain (Loss) | -1.21 | 5.4 | -0.12 | -13.75 | -4.36 |
Other Non Operating Income (Expenses) | 1.49 | 0.46 | -0.36 | 0.05 | 0.36 |
EBT Excluding Unusual Items | 176.28 | 149.6 | 114.92 | 79.55 | 24.6 |
Gain (Loss) on Sale of Investments | 0.3 | 0.15 | 0.67 | 0.25 | 0.03 |
Gain (Loss) on Sale of Assets | 0.18 | 0.1 | 0.05 | -3.32 | -0.01 |
Other Unusual Items | -2.61 | -5.17 | -2.56 | - | - |
Pretax Income | 174.16 | 144.67 | 113.08 | 76.49 | 24.62 |
Income Tax Expense | 29.11 | 23.51 | 17.97 | 11.81 | 6.23 |
Net Income | 145.05 | 121.16 | 95.11 | 64.68 | 18.39 |
Net Income to Common | 145.05 | 121.16 | 95.11 | 64.68 | 18.39 |
Net Income Growth | - | 27.39% | 47.05% | 251.71% | - |
Shares Outstanding (Basic) | 581 | 527 | 500 | 500 | 500 |
Shares Outstanding (Diluted) | 583 | 528 | 500 | 500 | 500 |
Shares Change | - | 5.59% | - | - | - |
EPS (Basic) | 0.25 | 0.23 | 0.19 | 0.13 | 0.04 |
EPS (Diluted) | 0.25 | 0.23 | 0.19 | 0.13 | 0.04 |
EPS Growth | - | 20.91% | 47.05% | 251.71% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 46.36 | 63.32 | 82.99 | 90.16 | -17.79 |
Free Cash Flow Per Share | 0.08 | 0.12 | 0.17 | 0.18 | -0.04 |
Dividend Per Share | 0.169 | 0.089 | - | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 36.48% | 35.87% | 35.24% | 34.94% | 22.99% |
Operating Margin | 26.14% | 25.24% | 25.41% | 22.91% | 11.11% |
Profit Margin | 22.47% | 21.36% | 20.93% | 15.72% | 5.75% |
Free Cash Flow Margin | 7.18% | 11.16% | 18.26% | 21.92% | -5.56% |
EBITDA | 181.25 | 152.22 | 123.22 | 101.89 | 42.38 |
EBITDA Margin | 28.08% | 26.83% | 27.12% | 24.77% | 13.25% |
D&A For EBITDA | 12.53 | 8.99 | 7.74 | 7.64 | 6.84 |
EBIT | 168.72 | 143.23 | 115.48 | 94.25 | 35.54 |
EBIT Margin | 26.14% | 25.24% | 25.41% | 22.91% | 11.11% |
Effective Tax Rate | 16.71% | 16.25% | 15.89% | 15.44% | 25.31% |